2019
DOI: 10.1002/mgg3.949
|View full text |Cite
|
Sign up to set email alerts
|

CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia

Abstract: BackgroundBiallelic variants of the CASQ2 are known to cause the autosomal recessive form of catecholaminergic polymorphic ventricular tachycardia (CPVT), an inherited disease that predisposes young individuals to syncope and sudden cardiac death. To date, only about 24 CASQ2 variants have been reported in association with CPVT pathogenesis; furthermore, studies in Asians, especially in the Chinese population, are relatively rare. The aim of this study was to detect CASQ2 variants in Chinese patients with CPVT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(18 citation statements)
references
References 25 publications
0
18
0
Order By: Relevance
“…Of note, CDK1 and KPNA2 were significantly upregulated in the Oncomine meta-analysis and thus were in line with our TCGA-BLCA analysis, while TPM1 was unaltered in the meta-analysis but significantly downregulated in our analysis ( Figure 5). CASQ2 seems to play a role in catecholaminergic polymorphic ventricular tachycardia research [57]. CRYAB was involved in a variety of signaling pathways implicated in breast cancer, lung cancer, prostate cancer, and ovarian cancer [58].…”
Section: The Hub Genes Are Potentially Associated With the Clinical Omentioning
confidence: 99%
“…Of note, CDK1 and KPNA2 were significantly upregulated in the Oncomine meta-analysis and thus were in line with our TCGA-BLCA analysis, while TPM1 was unaltered in the meta-analysis but significantly downregulated in our analysis ( Figure 5). CASQ2 seems to play a role in catecholaminergic polymorphic ventricular tachycardia research [57]. CRYAB was involved in a variety of signaling pathways implicated in breast cancer, lung cancer, prostate cancer, and ovarian cancer [58].…”
Section: The Hub Genes Are Potentially Associated With the Clinical Omentioning
confidence: 99%
“…A newly devised "phenotype-enhanced" scoring system for RYR2 variants has recently been described, which factors the pre-test probability of CPVT into the assignment of pathogenicity [95]. In addition, more than 24 pathogenic CASQ2 variants associated with CPVT have been identified to date [79]. Consanguineous family members are typically tested for CASQ2 variants.…”
Section: Genetic Testing Guidelines In Cpvtmentioning
confidence: 99%
“…A systematic search of the PubMed and MedRvix databases yielded 1049 and 12 articles, respectively. After the exclusion of overlapping cohorts, a total of 56 unique cases from six cities by 11 studies were included [11,25,[32][33][34][35][36][37][38][39][40]. Their clinical characteristics and test results are shown in Table 1.…”
Section: Clinical Characteristics Genetic Findings and Treatmentmentioning
confidence: 99%
“…Of these, catecholaminergic ventricular tachycardia (CPVT) is a less prevalent condition compared to Brugada syndrome (BrS) in Asia [7,8]. It is typically caused by mutations in either the ryanodine receptor 2 (RyR2) [9] or the calsequestrin 2 (CASQ2) [10,11], but mutations in other genes such as calmodulin (CALM) have been implicated [12][13][14]. CPVT is usually precipitated by exercise or distress, which results in bidirectional VT, presenting in the first two decades of life [15].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation